Catalent, Inc. logo

Catalent, Inc. Share Price Today (NYSE: CTLT)

Catalent, Inc. share price is $0 & ₹0.00 as on 16 Dec 2024 IST

-63.48

(-100%)

Market is closed - opens 7 PM, 14 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 17 Dec 2024

View live Catalent, Inc. share price in Dollar and Rupees. Guide to invest in Catalent, Inc. stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Catalent, Inc., along with analyst recommendations, forecasts, and comprehensive financials.

Catalent, Inc. (CTLT) Key Statistics

in dollars & INR

Previous Close
$63.48
Open
$63.49
Market Capitalization
$11.5B
Today's Volume
$14.2M
Revenue TTM
$4.4B
EBITDA
$462.0M
Earnings Per Share (EPS)
$-2.28
Profit Margin
-9.34%
Quarterly Earnings Growth YOY
-0.15%
Return On Equity TTM
-11.19%

How to invest in Catalent, Inc. Stock (CTLT) from India?

It is very easy for Indian residents to invest directly in Catalent, Inc. from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Catalent, Inc. stock in both Indian Rupees (INR) and US Dollars (USD). Search for Catalent, Inc. or CTLT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Catalent, Inc. or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Catalent, Inc. shares which would translate to null fractional shares of Catalent, Inc. as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Catalent, Inc., in just a few clicks!

Global Institutional Holdings in Catalent, Inc.

  • Vanguard Group Inc

    11.15%

  • BlackRock Inc

    8.46%

  • State Street Corp

    4.11%

  • Capital World Investors

    3.53%

  • NORGES BANK

    2.53%

  • Millennium Management LLC

    2.49%

Analyst Recommendation on Catalent, Inc.

Rating
Trend

Hold

    41%Buy

    58%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Catalent, Inc.(by analysts ranked 0 to 5 stars)

CTLT Catalent, Inc. Financials in INR & Dollars

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$4.4B
↑ 2.46%
Net Income
$-1.0B
↑ 349.57%
Net Profit Margin
-23.81%
↓ 18.38%

About Catalent, Inc.

Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates in two segments, Biologics, and Pharma and Consumer Health. The Biologics segment provides formulation, development, and manufacturing for biologic proteins, cell gene, and other nucleic acid therapies; pDNA, iPSCs, oncolytic viruses, and vaccines; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, and cartridges; and analytical development and testing services for large molecules. The Pharma and Consumer Health segment offers formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations; and oral, nasal, inhaled, and topical dose forms. This segment also provides clinical supply services through manufacturing, packaging, storage, distribution, and inventory management for small-molecule drugs, protein-based biologics, and cell and gene therapies in clinical trials; and pre-clinical screening, formulation, analytical development, and current good manufacturing practices manufacturing at clinical and commercial scale for softgel capsule, Zydis fast-dissolve tablets, oral solid-dose formats, dry powder inhalers, and nasal delivery devices. The company also offers FlexDirect direct-to-patient and FastChain demand-led clinical supply solutions; fill and finish operations for injectable products; and integrated development and product supply chain solutions. It serves biotechnology, pharmaceutical, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. The company was founded in 1933 and is headquartered in Somerset, New Jersey.
Organization
Catalent, Inc.
Employees
17000
CEO
Mr. John J. Greisch M.B.A.
Industry
Health Technology

Management People of Catalent, Inc.

NameTitle
Mr. John J. Greisch M.B.A.
Executive Chairman of the Board
Mr. Alessandro Maselli
President, CEO & Director
Mr. Matti M. Masanovich
Senior VP & CFO
Ms. Lisa Evoli
Senior VP & Chief Human Resources Officer
Mr. Ricky Hopson
President, Division Head for BioProduct Delivery & Chief of Staff
Mr. David McErlane
Group President of Biologics Segment
Mr. Michael J. Hatzfeld Jr.
VP & Chief Accounting Officer
Mr. Charles Lickfold
Senior VP & Chief Information Officer
Mr. Paul Surdez
Vice President of Investor Relations
Mr. Joseph A. Ferraro J.D.
Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary

Important FAQs about investing in CTLT Stock from India :

Can Indians buy Catalent, Inc. shares?

Yes, Indians can invest in the Catalent, Inc. (CTLT) from India.

With INDmoney, you can buy Catalent, Inc. at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Catalent, Inc. at zero transaction cost.

How can I buy Catalent, Inc. shares from India?

It is very easy to buy Catalent, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Catalent, Inc. (CTLT) be purchased?

Yes, you can buy fractional shares of Catalent, Inc. with INDmoney app.

What are the documents required to start investing in Catalent, Inc. stocks?

To start investing in Catalent, Inc., You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Catalent, Inc.?

Today's market capitalisation of Catalent, Inc. CTLT is 11.5B

Who is the Chief Executive Officer (CEO) of Catalent, Inc. ?

Mr. John J. Greisch M.B.A. is the current Chief Executive Officer (CEO) of Catalent, Inc..